{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:16:27Z","timestamp":1791656187579,"version":"4.3.4"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11499-1","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:53:35Z","timestamp":1773316415000},"page":"6715-6767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rational drug design and synthesis of novel bioactive molecules with oxygen heterocycles, including AChE and BChE inhibitory properties and SAR studies"],"prefix":"10.1007","volume":"30","author":[{"given":"Rajarshi","family":"Nath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumel","family":"Ashique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupender","family":"Nehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja A","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah M.","family":"Al-Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Yasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Sadique","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshminarayan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arka","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aganta","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathvik Belagodu","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biplab","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6365-7104","authenticated-orcid":false,"given":"Md Yousuf","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"11499_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint17020026","author":"N Puranik","year":"2025","unstructured":"Puranik N, Song M (2025) Therapeutic role of heterocyclic compounds in neurodegenerative diseases: insights from Alzheimer\u2019s and Parkinson\u2019s diseases. Neurol Int. https:\/\/doi.org\/10.3390\/neurolint17020026","journal-title":"Neurol Int"},{"key":"11499_CR2","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1002\/cbic.201800225","volume":"19","author":"S Meng","year":"2018","unstructured":"Meng S, Tang GL, Pan HX (2018) Enzymatic formation of oxygen-containing heterocycles in natural product biosynthesis. ChemBioChem 19:2002\u20132022","journal-title":"ChemBioChem"},{"key":"11499_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ph16121668","author":"JLC Sousa","year":"2023","unstructured":"Sousa JLC, Albuquerque HMT, Silva AMS (2023) Drug discovery based on oxygen and nitrogen (non-)heterocyclic compounds developed @LAQV-REQUIMTE\/Aveiro. Pharmaceut (Basel, Switzerland). https:\/\/doi.org\/10.3390\/ph16121668","journal-title":"Pharmaceut (Basel, Switzerland)"},{"key":"11499_CR4","doi-asserted-by":"publisher","first-page":"16852","DOI":"10.3390\/molecules200916852","volume":"20","author":"P Martins","year":"2015","unstructured":"Martins P, Jesus J, Santos S, Raposo LR, Roma-Rodrigues C, Baptista PV et al (2015) Heterocyclic anticancer compounds: recent advances and the paradigm shift towards the use of nanomedicine\u2019s tool box. Molecules 20:16852\u201316891","journal-title":"Molecules"},{"key":"11499_CR5","doi-asserted-by":"publisher","DOI":"10.2174\/0118741045372896250619051210","author":"T Khamkar","year":"2025","unstructured":"Khamkar T, Kadam R, Mali SS, Udugade B, Singh S (2025) Recent advances in synthetic approaches for 1, 3, 4-oxadiazole derivatives: a comprehensive review on therapeutic applications. Open Med Chem J. https:\/\/doi.org\/10.2174\/0118741045372896250619051210","journal-title":"Open Med Chem J"},{"key":"11499_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202200123","volume":"355","author":"N Desai","year":"2022","unstructured":"Desai N, Monapara J, Jethawa A, Khedkar V, Shingate B (2022) Oxadiazole: a highly versatile scaffold in drug discovery. Arch Pharm (Weinheim) 355:e2200123","journal-title":"Arch Pharm (Weinheim)"},{"key":"11499_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25071594","author":"X Zheng","year":"2020","unstructured":"Zheng X, Liu W, Zhang D (2020) Recent advances in the synthesis of oxazole-based molecules via van Leusen oxazole synthesis. Molecules (Basel, Switzerland). https:\/\/doi.org\/10.3390\/molecules25071594","journal-title":"Molecules (Basel, Switzerland)"},{"key":"11499_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112874","volume":"209","author":"M Wang","year":"2021","unstructured":"Wang M, Liu T, Chen S, Wu M, Han J, Li Z (2021) Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3\u03b2 inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents. Eur J Med Chem 209:112874","journal-title":"Eur J Med Chem"},{"key":"11499_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ph13060111","author":"K Biernacki","year":"2020","unstructured":"Biernacki K, Da\u015bko M, Ciupak O, Kubi\u0144ski K, Rachon J, Demkowicz S (2020) Novel 1,2,4-oxadiazole derivatives in drug discovery. Pharmaceuticals (Basel, Switzerland). https:\/\/doi.org\/10.3390\/ph13060111","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"11499_CR10","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jhet.3842","volume":"57","author":"P Rayam","year":"2020","unstructured":"Rayam P, Polkam N, Kuntala N, Banothu V, Anantaraju HS, Perumal Y et al (2020) Design and synthesis of oxaprozin\u20101, 3, 4\u2010oxadiazole hybrids as potential anticancer and antibacterial agents. J Heterocycl Chem 57:1071\u20131082","journal-title":"J Heterocycl Chem"},{"key":"11499_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03217","volume":"6","author":"S Mishra","year":"2020","unstructured":"Mishra S, Pandey A, Manvati S (2020) Coumarin: an emerging antiviral agent. Heliyon 6:e03217","journal-title":"Heliyon"},{"key":"11499_CR12","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.2174\/1389557521666210405160323","volume":"21","author":"N Bhattarai","year":"2021","unstructured":"Bhattarai N, Kumbhar AA, Pokharel YR, Yadav PN (2021) Anticancer potential of coumarin and its derivatives. Mini Rev Med Chem 21:2996\u20133029","journal-title":"Mini Rev Med Chem"},{"key":"11499_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103578","volume":"96","author":"A Kumari","year":"2020","unstructured":"Kumari A, Singh RK (2020) Morpholine as ubiquitous pharmacophore in medicinal chemistry: deep insight into the structure-activity relationship (SAR). Bioorg Chem 96:103578","journal-title":"Bioorg Chem"},{"key":"11499_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/med.21634","volume":"40","author":"AP Kourounakis","year":"2020","unstructured":"Kourounakis AP, Xanthopoulos D, Tzara A (2020) Morpholine as a privileged structure: a review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules. Med Res Rev 40:709\u2013752","journal-title":"Med Res Rev"},{"key":"11499_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13765-025-01018-5","volume":"68","author":"MT He","year":"2025","unstructured":"He MT, Kim SJ, Le VD, Min SJ, Lee H, Lee JW et al (2025) Novel pyran-based anti-inflammatory agents: design, synthesis, and mechanistic studies in LPS-stimulated macrophages. Appl Biol Chem 68:47","journal-title":"Appl Biol Chem"},{"key":"11499_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59193-2","volume":"14","author":"A El-Wahab","year":"2024","unstructured":"El-Wahab A, Borik RM, Al-Dies AM, Fouda AM, Mohamed HM, El-Eisawy RA et al (2024) Targeted potent antimicrobial and antitumor oxygen-heterocyclic-based pyran analogues: synthesis and computational studies. Sci Rep 14:9862","journal-title":"Sci Rep"},{"key":"11499_CR17","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.2174\/1871520621666211119090302","volume":"22","author":"P Grover","year":"2022","unstructured":"Grover P, Bhardwaj M, Mehta L, Kapoor G, Chawla PA (2022) Current developments in the pyran-based analogues as anticancer agents. Anticancer Agents Med Chem 22:3239\u20133268","journal-title":"Anticancer Agents Med Chem"},{"key":"11499_CR18","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1007\/s12010-022-04099-w","volume":"194","author":"H Sachdeva","year":"2022","unstructured":"Sachdeva H, Khaturia S, Saquib M, Khatik N, Khandelwal AR, Meena R et al (2022) Oxygen- and sulphur-containing heterocyclic compounds as potential anticancer agents. Appl Biochem Biotechnol 194:6438\u20136467","journal-title":"Appl Biochem Biotechnol"},{"key":"11499_CR19","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1016\/j.bmcl.2009.03.069","volume":"19","author":"SA Galal","year":"2009","unstructured":"Galal SA, Abd El-All AS, Abdallah MM, El-Diwani HI (2009) Synthesis of potent antitumor and antiviral benzofuran derivatives. Bioorg Med Chem Lett 19:2420\u20132428","journal-title":"Bioorg Med Chem Lett"},{"key":"11499_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0301-0082(99)00047-7","volume":"60","author":"A Mack","year":"2000","unstructured":"Mack A, Robitzki A (2000) The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5\u2019butyrylcholinesterase-DNA study. Prog Neurobiol 60:607\u2013628","journal-title":"Prog Neurobiol"},{"key":"11499_CR21","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/jnc.15243","volume":"158","author":"CN Metz","year":"2021","unstructured":"Metz CN, Pavlov VA (2021) Treating disorders across the lifespan by modulating cholinergic signaling with galantamine. J Neurochem 158:1359\u20131380","journal-title":"J Neurochem"},{"key":"11499_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70503","volume":"31","author":"MS Hussain","year":"2025","unstructured":"Hussain MS, Agrawal N, Ilma B, Mr M, Nayak PP, Kaur M et al (2025) Autophagy and cellular senescence in Alzheimer\u2019s disease: key drivers of neurodegeneration. CNS Neurosci Ther 31:e70503","journal-title":"CNS Neurosci Ther"},{"key":"11499_CR23","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1080\/10286020.2024.2371040","volume":"26","author":"Z Hui","year":"2024","unstructured":"Hui Z, Lai-Fa W, Xue-Qin W, Ling D, Bin-Sheng H, Li JM (2024) Mechanisms and therapeutic potential of chinonin in nervous system diseases. J Asian Nat Prod Res 26:1405\u20131420","journal-title":"J Asian Nat Prod Res"},{"key":"11499_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27061816","author":"ZR Chen","year":"2022","unstructured":"Chen ZR, Huang JB, Yang SL, Hong FF (2022) Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules. https:\/\/doi.org\/10.3390\/molecules27061816","journal-title":"Molecules"},{"key":"11499_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108352","volume":"190","author":"G Marucci","year":"2021","unstructured":"Marucci G, Buccioni M, Ben DD D, Lambertucci C, Volpini R, Amenta F (2021) Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease. Neuropharmacology 190:108352","journal-title":"Neuropharmacology"},{"key":"11499_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4103\/0253-7613.161274","volume":"47","author":"S Kumar","year":"2015","unstructured":"Kumar S (2015) Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin. Indian J Pharmacol 47:444\u2013446","journal-title":"Indian J Pharmacol"},{"key":"11499_CR27","doi-asserted-by":"publisher","first-page":"19764","DOI":"10.1039\/D2RA03081K","volume":"12","author":"RJ Obaid","year":"2022","unstructured":"Obaid RJ, Naeem N, Mughal EU, Al-Rooqi MM, Sadiq A, Jassas RS et al (2022) Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase. RSC Adv 12:19764\u201319855","journal-title":"RSC Adv"},{"key":"11499_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1609793","volume":"17","author":"P Yu","year":"2025","unstructured":"Yu P, Shen L, Tang L (2025) Multimodal DTI-ALPS and hippocampal microstructural signatures unveil stage-specific pathways in Alzheimer\u2019s disease progression. Front Aging Neurosci 17:1609793","journal-title":"Front Aging Neurosci"},{"key":"11499_CR29","volume":"12","author":"A Sobha","year":"2024","unstructured":"Sobha A, Ganapathy A, Mohan S, Madhusoodanan N, Babysulochana AD, Alaganandan K et al (2024) Novel small molecule-based acetylcholinesterase (AChE) inhibitors: from biological perspective to recent developments. European J Med Chem Report 12:100237","journal-title":"European J Med Chem Report"},{"key":"11499_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178726","author":"W Grabowska","year":"2025","unstructured":"Grabowska W, Bijak M, Szelenberger R, Gorniak L, Podogrocki M, Harmata P et al (2025) Acetylcholinesterase as a multifunctional target in amyloid-driven neurodegeneration: from dual-site inhibitors to anti-agregation strategies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26178726","journal-title":"Int J Mol Sci"},{"key":"11499_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30102093","author":"L Li","year":"2025","unstructured":"Li L, Zhao P, Yang C, Yin Q, Wang N, Liu Y et al (2025) Discovery, biological evaluation and binding mode investigation of novel butyrylcholinesterase inhibitors through hybrid virtual screening. Molecules. https:\/\/doi.org\/10.3390\/molecules30102093","journal-title":"Molecules"},{"key":"11499_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031084","author":"SC Peitzika","year":"2023","unstructured":"Peitzika SC, Pontiki E (2023) A review on recent approaches on molecular docking studies of novel compounds targeting acetylcholinesterase in Alzheimer disease. Molecules (Basel, Switzerland). https:\/\/doi.org\/10.3390\/molecules28031084","journal-title":"Molecules (Basel, Switzerland)"},{"key":"11499_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.143519","volume":"1349","author":"A Jaggal","year":"2025","unstructured":"Jaggal A, Katagi KS, Akki M, Babagond V, Kamat V, Barretto DA et al (2025) Design and synthesis of potent coumarin-1, 2, 3-triazole conjugates: An approach to docking studies for their therapeutic applications. J Mol Struct 1349:143519","journal-title":"J Mol Struct"},{"key":"11499_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102271","volume":"15","author":"HEN Khasawneh","year":"2025","unstructured":"Khasawneh HEN, Alrikabi AAA, AL-Erjan AM, Kadham MJ, Al-Aouadi RFA, Lakshmaiya N et al (2025) Unveiling the therapeutic potential of 1, 2, 4-oxadiazole derivatives: an updated review. Results Chem 15:102271","journal-title":"Results Chem"},{"key":"11499_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911231","author":"C Liu","year":"2022","unstructured":"Liu C, Wang LN, Liu YM (2022) Novel morpholine-bearing quinoline derivatives as potential cholinesterase inhibitors: the influence of amine, carbon linkers and phenylamino groups. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231911231","journal-title":"Int J Mol Sci"},{"key":"11499_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102949","volume":"88","author":"C Wu","year":"2019","unstructured":"Wu C, Tu YB, Li Z, Li YF (2019) Highly selective carbamate-based butyrylcholinesterase inhibitors derived from a naturally occurring pyranoisoflavone. Bioorg Chem 88:102949","journal-title":"Bioorg Chem"},{"key":"11499_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115766","volume":"260","author":"SS Abd El-Karim","year":"2023","unstructured":"Abd El-Karim SS, Anwar MM, Ahmed NS, Syam YM, Elseginy SA, Aly HF et al (2023) Discovery of novel benzofuran-based derivatives as acetylcholinesterase inhibitors for the treatment of Alzheimer\u2019s disease: design, synthesis, biological evaluation, molecular docking and 3D-QSAR investigation. Eur J Med Chem 260:115766","journal-title":"Eur J Med Chem"},{"key":"11499_CR38","doi-asserted-by":"publisher","first-page":"10403","DOI":"10.1021\/acs.chemrev.9b00145","volume":"119","author":"D Cao","year":"2019","unstructured":"Cao D, Liu Z, Verwilst P, Koo S, Jangjili P, Kim JS et al (2019) Coumarin-based small-molecule fluorescent chemosensors. Chem Rev 119:10403\u201310519","journal-title":"Chem Rev"},{"key":"11499_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134618","author":"F Annunziata","year":"2020","unstructured":"Annunziata F, Pinna C, Dallavalle S, Tamborini L, Pinto A (2020) An overview of coumarin as a versatile and readily accessible scaffold with broad-ranging biological activities. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21134618","journal-title":"Int J Mol Sci"},{"key":"11499_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1039\/JS8682100053","volume":"21","author":"W Perkin","year":"1868","unstructured":"Perkin W (1868) On the artificial production of coumarin and formation of its homologues. J Chem Soc 21:53\u201363","journal-title":"J Chem Soc"},{"key":"11499_CR41","volume":"10","author":"B Debnath","year":"2025","unstructured":"Debnath B, Manna S, Maity A, Panda S, Bandyopadhyay K, Bhattacharjee S et al (2025) Synthetic strategies and structure activity relationships (SAR) of biologically active coumarin\u2010based hybrids. Chem Select 10:e202406069","journal-title":"Chem Select"},{"key":"11499_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejmech.2015.06.017","volume":"100","author":"RS Keri","year":"2015","unstructured":"Keri RS, Sasidhar BS, Nagaraja BM, Santos MA (2015) Recent progress in the drug development of coumarin derivatives as\u00a0potent antituberculosis agents. Eur J Med Chem 100:257\u2013269","journal-title":"Eur J Med Chem"},{"key":"11499_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30081830","author":"M Rullo","year":"2025","unstructured":"Rullo M, Benzi A, Bianchi L, Maccagno M, Marcantoni Taddei G, Miniero DV et al (2025) In vitro evaluation of novel furo[3,2-c]coumarins as cholinesterases and monoamine oxidases inhibitors. Molecules. https:\/\/doi.org\/10.3390\/molecules30081830","journal-title":"Molecules"},{"key":"11499_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30102121","author":"A Dimkovski","year":"2025","unstructured":"Dimkovski A, Dobri\u010di\u0107 V, Simi\u0107 MR, Jurhar Pavlova M, Mihajloska E, Sterjev Z et al (2025) Synthesis, biological evaluation, and molecular docking studies of novel coumarin-triazole-isatin hybrids as selective butyrylcholinesterase inhibitors. Molecules. https:\/\/doi.org\/10.3390\/molecules30102121","journal-title":"Molecules"},{"key":"11499_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27072121","author":"S Haji Ali","year":"2022","unstructured":"Haji Ali S, Osmaniye D, Sa\u011fl\u0131k BN, Levent S, \u00d6zkay Y, Kaplanc\u0131kl\u0131 ZA (2022) Design, synthesis, and evaluation of novel 2H-benzo[b][1,4]thiazin-3(4H)-one derivatives as new acetylcholinesterase inhibitors. Molecules. https:\/\/doi.org\/10.3390\/molecules27072121","journal-title":"Molecules"},{"key":"11499_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312803","author":"T \u017bo\u0142ek","year":"2024","unstructured":"\u017bo\u0142ek T, Purgatorio R, K\u0142opotowski \u0141, Catto M, Ostrowska K (2024) Coumarin derivative hybrids: novel dual inhibitors targeting acetylcholinesterase and monoamine oxidases for Alzheimer\u2019s therapy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252312803","journal-title":"Int J Mol Sci"},{"key":"11499_CR47","doi-asserted-by":"publisher","first-page":"11450","DOI":"10.1080\/07391102.2022.2162583","volume":"41","author":"AH Hasan","year":"2023","unstructured":"Hasan AH, Shakya S, Hussain FHS, Murugesan S, Chander S, Pratama MRF et al (2023) Design, synthesis, anti-acetylcholinesterase evaluation and molecular modelling studies of novel coumarin-chalcone hybrids. J Biomol Struct Dyn 41:11450\u201311462","journal-title":"J Biomol Struct Dyn"},{"key":"11499_CR48","doi-asserted-by":"publisher","first-page":"18496","DOI":"10.1039\/D3RA02344C","volume":"13","author":"NN Kamel","year":"2023","unstructured":"Kamel NN, Aly HF, Fouad GI, Abd El-Karim SS, Anwar MM, Syam YM et al (2023) Anti-Alzheimer activity of new coumarin-based derivatives targeting acetylcholinesterase inhibition. RSC Adv 13:18496\u201318510","journal-title":"RSC Adv"},{"key":"11499_CR49","doi-asserted-by":"publisher","first-page":"11161","DOI":"10.1021\/acsomega.2c07993","volume":"8","author":"A Sharma","year":"2023","unstructured":"Sharma A, Bharate SB (2023) Synthesis and biological evaluation of coumarin triazoles as dual inhibitors of cholinesterases and \u03b2-secretase. ACS Omega 8:11161\u201311176","journal-title":"ACS Omega"},{"key":"11499_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110655","volume":"383","author":"H \u00c7elik Onar","year":"2023","unstructured":"\u00c7elik Onar H, \u00d6zden EM, Taslak HD, G\u00fcl\u00e7in \u0130, Ece A, Er\u00e7a\u011f E (2023) Novel coumarin-chalcone derivatives: synthesis, characterization, antioxidant, cyclic voltammetry, molecular modelling and biological evaluation studies as acetylcholinesterase, \u03b1-glycosidase, and carbonic anhydrase inhibitors. Chem Biol Interact 383:110655","journal-title":"Chem Biol Interact"},{"key":"11499_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27072142","author":"F Zeng","year":"2022","unstructured":"Zeng F, Lu T, Wang J, Nie X, Xiong W, Yin Z et al (2022) Design, synthesis and bioactivity evaluation of coumarin-BMT hybrids as new acetylcholinesterase inhibitors. Molecules. https:\/\/doi.org\/10.3390\/molecules27072142","journal-title":"Molecules"},{"key":"11499_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2022.108210","volume":"115","author":"FC Onder","year":"2022","unstructured":"Onder FC, Sahin K, Senturk M, Durdagi S, Ay M (2022) Identifying highly effective coumarin-based novel cholinesterase inhibitors by in silico and in vitro studies. J Mol Graph Model 115:108210","journal-title":"J Mol Graph Model"},{"key":"11499_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116314","author":"D Karcz","year":"2022","unstructured":"Karcz D, Starzak K, Ciszkowicz E, Lecka-Szlachta K, Kami\u0144ski D, Creaven B et al (2022) Design, spectroscopy, and assessment of cholinesterase inhibition and antimicrobial activities of novel coumarin-thiadiazole hybrids. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23116314","journal-title":"Int J Mol Sci"},{"key":"11499_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12039-007-0007-7","volume":"119","author":"PV Frank","year":"2007","unstructured":"Frank PV, Girish K, Kalluraya B (2007) Solvent-free microwave-assisted synthesis of oxadiazoles containing imidazole moiety. J Chem Sci 119:41\u201346","journal-title":"J Chem Sci"},{"key":"11499_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041163","author":"BK Banik","year":"2021","unstructured":"Banik BK, Sahoo BM, Kumar B, Panda KC, Jena J, Mahapatra MK et al (2021) Green synthetic approach: an efficient eco-friendly tool for synthesis of biologically active oxadiazole derivatives. Molecules. https:\/\/doi.org\/10.3390\/molecules26041163","journal-title":"Molecules"},{"key":"11499_CR56","volume":"7","author":"HB Kucuk","year":"2022","unstructured":"Kucuk HB, Alhonaish A, Yildiz T, Guzel M (2022) An efficient approach to access 2, 5\u2010disubstituted 1, 3, 4\u2010oxadiazoles by oxidation of 2\u2010arenoxybenzaldehyde N\u2010acyl hydrazones with molecular iodine. ChemSelect 7:e202201391","journal-title":"ChemSelect"},{"key":"11499_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.142615","volume":"1341","author":"QU Ain","year":"2025","unstructured":"Ain QU, Ullah H, Taha M, Rahim F, Uddin N, Khan S et al (2025) New Benzodioxine based oxadiazole Analogues as a Potent Anti-Alzheimer\u2019s Agents. J Mol Struct 1341:142615","journal-title":"J Mol Struct"},{"key":"11499_CR58","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1039\/D4MD00113C","volume":"15","author":"MS Ayoup","year":"2024","unstructured":"Ayoup MS, Barakat MR, Abdel-Hamid H, Emam E, Al-Faiyz YS, Masoud AA et al (2024) Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-Alzheimer agents. RSC Med Chem 15:2080\u20132097","journal-title":"RSC Med Chem"},{"key":"11499_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400115","volume":"357","author":"AE Evren","year":"2024","unstructured":"Evren AE, Nuha D, \u00d6zkan BNS, Kahraman \u00c7, G\u00f6n\u00fclalan EM, Yurtta\u015f L (2024) Design and synthesis of phenoxy methyl-oxadiazole compounds against Alzheimer\u2019s disease. Arch Pharm (Weinheim) 357:e2400115","journal-title":"Arch Pharm (Weinheim)"},{"key":"11499_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2022.101977","volume":"34","author":"N George","year":"2022","unstructured":"George N, Sabahi BA, AbuKhader M, Balushi KA, Akhtar MJ, Khan SA (2022) Design, synthesis and in vitro biological activities of coumarin linked 1, 3, 4-oxadiazole hybrids as potential multi-target directed anti-Alzheimer agents. J King Saud Univ Sci 34:101977","journal-title":"J King Saud Univ Sci"},{"key":"11499_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ph15040400","author":"V Pfl\u00e9gr","year":"2022","unstructured":"Pfl\u00e9gr V, \u0160t\u011bp\u00e1nkov\u00e1 \u0160, Svr\u010dkov\u00e1 K, \u0160varcov\u00e1 M, Vin\u0161ov\u00e1 J, Kr\u00e1tk\u00fd M (2022) 5-Aryl-1,3,4-oxadiazol-2-amines decorated with long alkyl and their analogues: synthesis, acetyl- and butyrylcholinesterase inhibition and docking study. Pharmaceut (Basel, Switzerland). https:\/\/doi.org\/10.3390\/ph15040400","journal-title":"Pharmaceut (Basel, Switzerland)"},{"key":"11499_CR62","doi-asserted-by":"publisher","first-page":"29847","DOI":"10.1021\/jacs.4c11708","volume":"146","author":"KG Ortiz","year":"2024","unstructured":"Ortiz KG, Brusoe AT, An J, Chong E, Wu L (2024) Green synthesis of morpholines via selective monoalkylation of amines. J Am Chem Soc 146:29847\u201329856","journal-title":"J Am Chem Soc"},{"key":"11499_CR63","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1021\/ol300030w","volume":"14","author":"Z Lu","year":"2012","unstructured":"Lu Z, Stahl SS (2012) Intramolecular Pd(II)-catalyzed aerobic oxidative amination of alkenes: synthesis of six-membered N-heterocycles. Org Lett 14:1234\u20131237","journal-title":"Org Lett"},{"key":"11499_CR64","first-page":"525","volume":"32","author":"T Aubineau","year":"2021","unstructured":"Aubineau T, Dupas A, Zeng T, Cossy J (2021) Iron-catalyzed diastereoselective synthesis of disubstituted morpholines via C\u2013O or C\u2013N bond formation. Synlett 32:525\u2013531","journal-title":"Synlett"},{"key":"11499_CR65","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.1021\/acs.orglett.5b02516","volume":"17","author":"JV Matlock","year":"2015","unstructured":"Matlock JV, Svejstrup TD, Songara P, Overington S, McGarrigle EM, Aggarwal VK (2015) Synthesis of 6- and 7-membered N-heterocycles using \u03b1-phenylvinylsulfonium salts. Org Lett 17:5044\u20135047","journal-title":"Org Lett"},{"key":"11499_CR66","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.scib.2024.06.005","volume":"70","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Lam SM, Zhang S, Miao H, Zhou Y, Zhang Q et al (2025) CSF multi-omics of intracerebral hemorrhage from onset to reperfusion underscores lipid metabolism in functional outcome. Science bulletin 70:162\u2013166","journal-title":"Science bulletin"},{"key":"11499_CR67","first-page":"545","volume":"6","author":"M Pulch","year":"1955","unstructured":"Pulch M (1955) [Preludin in therapy of obesity]. Dtsch Med J 6:545\u2013546","journal-title":"Dtsch Med J"},{"key":"11499_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.55971\/EJLS.1497639","volume":"3","author":"B Kurban","year":"2024","unstructured":"Kurban B, Osmaniye D, \u00d6zkan BNS, Kaplanc\u0131kl\u0131 ZA (2024) Investigation of dual AChE\/MAO inhibitory activities of new morpholine and piperazine structured compounds. Eur J Life Sci 3:55\u201365","journal-title":"Eur J Life Sci"},{"key":"11499_CR69","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/14756366.2020.1842390","volume":"36","author":"R Sasidharan","year":"2021","unstructured":"Sasidharan R, Eom BH, Heo JH, Park JE, Abdelgawad MA, Musa A et al (2021) Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations. J Enzyme Inhib Med Chem 36:188\u2013197","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11499_CR70","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1080\/00397911.2021.1970774","volume":"51","author":"AE Mekky","year":"2021","unstructured":"Mekky AE, Sanad SM, El-Idreesy TT (2021) New thiazole and thiazole-chromene hybrids possessing morpholine units: piperazine-mediated one-pot synthesis of potential acetylcholinesterase inhibitors. Synth Commun 51:3332\u20133344","journal-title":"Synth Commun"},{"key":"11499_CR71","volume-title":"Natural products as source of molecules with therapeutic potentia","author":"W Szeja","year":"2018","unstructured":"Szeja W, Grynkiewicz G (2018) Syntheses of asymmetrically substituted pyrans of natural origin. Natural products as source of molecules with therapeutic potentia. Springer, Cham"},{"key":"11499_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.127785","volume":"1207","author":"B Chowhan","year":"2020","unstructured":"Chowhan B, Gupta M, Sharma N, Frontera A (2020) DFT analysis of supra-molecular assemblies of substituted 4H-pyran derivatives. J Mol Struct 1207:127785","journal-title":"J Mol Struct"},{"key":"11499_CR73","doi-asserted-by":"publisher","first-page":"36977","DOI":"10.1039\/C7RA05441F","volume":"7","author":"D Kumar","year":"2017","unstructured":"Kumar D, Sharma P, Singh H, Nepali K, Gupta GK, Jain SK et al (2017) The value of pyrans as anticancer scaffolds in medicinal chemistry. RSC Adv 7:36977\u201336999","journal-title":"RSC Adv"},{"key":"11499_CR74","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1021\/acs.joc.3c00050","volume":"88","author":"C D\u00edez-Poza","year":"2023","unstructured":"D\u00edez-Poza C, Fern\u00e1ndez-Pe\u00f1a L, Gonz\u00e1lez-Andr\u00e9s P, Barbero A (2023) Changing the reaction pathway of silyl-Prins cyclization by switching the Lewis acid: application to the synthesis of an antinociceptive compound. J Org Chem 88:6776\u20136783","journal-title":"J Org Chem"},{"key":"11499_CR75","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1134\/S1070363216060128","volume":"86","author":"N Chernov","year":"2016","unstructured":"Chernov N, Filippova P, Yakovlev I, Zakhs V, Belyakov A (2016) Synthesis and reactivity of 4-hydroxy-5-methyl-2-(2-oxo-2 H-chromen-3-yl)-6 H-1, 3-oxazin-6-ones. Russ J Gen Chem 86:1292\u20131299","journal-title":"Russ J Gen Chem"},{"key":"11499_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.142822","volume":"1343","author":"J Zhang","year":"2025","unstructured":"Zhang J, Tang Z, Weng G-J, Lu J-M, Shao L-X (2025) One-pot, three-component synthesis of 4H-pyrans catalyzed by one-dimensional zinc-organic frameworks. J Mol Struct 1343:142822","journal-title":"J Mol Struct"},{"key":"11499_CR77","doi-asserted-by":"publisher","first-page":"8132","DOI":"10.1021\/ja061344d","volume":"128","author":"BD Sherry","year":"2006","unstructured":"Sherry BD, Maus L, Laforteza BN, Toste FD (2006) Gold(I)-catalyzed synthesis of dihydropyrans. J Am Chem Soc 128:8132\u20138133","journal-title":"J Am Chem Soc"},{"key":"11499_CR78","doi-asserted-by":"publisher","first-page":"18279","DOI":"10.1039\/c3ra43526a","volume":"3","author":"SJ Gharpure","year":"2013","unstructured":"Gharpure SJ, Sathiyanarayanan A, Vuram PK (2013) Hetero Diels\u2013Alder reaction of olefin with o-quinone methides generated using (\u00b1)-binolphosphoric acid for the stereoselective synthesis of 2, 4-diarylbenzopyrans: application to the formal synthesis of myristinin B\/C. RSC Adv 3:18279\u201318282","journal-title":"RSC Adv"},{"key":"11499_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060855","author":"T Murphy","year":"2020","unstructured":"Murphy T, Le Foll B (2020) Targeting the endocannabinoid CB1 receptor to treat body weight disorders: a preclinical and clinical review of the therapeutic potential of past and present CB1 drugs. Biomolecules. https:\/\/doi.org\/10.3390\/biom10060855","journal-title":"Biomolecules"},{"key":"11499_CR80","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/phar.1709","volume":"36","author":"CC Tsang","year":"2016","unstructured":"Tsang CC, Giudice MG (2016) Nabilone for the management of pain. Pharmacotherapy 36:273\u2013286","journal-title":"Pharmacotherapy"},{"key":"11499_CR81","doi-asserted-by":"publisher","first-page":"11434","DOI":"10.1080\/07391102.2021.1962407","volume":"40","author":"RA Jeyaram","year":"2022","unstructured":"Jeyaram RA, Anu Radha C (2022) N1 neuraminidase of H5N1 avian influenza A virus complexed with sialic acid and zanamivir - A study by molecular docking and molecular dynamics simulation. J Biomol Struct Dyn 40:11434\u201311447","journal-title":"J Biomol Struct Dyn"},{"key":"11499_CR82","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1586\/eri.11.112","volume":"9","author":"H Ikematsu","year":"2011","unstructured":"Ikematsu H, Kawai N (2011) Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza. Expert Rev Anti Infect Ther 9:851\u2013857","journal-title":"Expert Rev Anti Infect Ther"},{"key":"11499_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01614940.2022.2041303","volume":"66","author":"RN Yadav","year":"2024","unstructured":"Yadav RN, Hossain MF, Das A, Srivastava AK, Banik BK (2024) Organocatalysis: a recent development on stereoselective synthesis of o-glycosides. Catal Rev 66:1\u2013118","journal-title":"Catal Rev"},{"key":"11499_CR84","doi-asserted-by":"publisher","first-page":"2313682","DOI":"10.1080\/14756366.2024.2313682","volume":"39","author":"C Yu","year":"2024","unstructured":"Yu C, Liu X, Ma B, Xu J, Chen Y, Dai C et al (2024) Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer\u2019s disease. J Enzyme Inhib Med Chem 39:2313682","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11499_CR85","doi-asserted-by":"publisher","DOI":"10.1177\/1934578X231201037","author":"NH Thanh","year":"2023","unstructured":"Thanh NH, Giang NT, Ha NV, Tha PH, Thuy GLN, Tuan AN et al (2023) Synthesis and evaluation of acetylcholinesterase inhibitory and cytotoxic activities of pyrano [2, 3-d] pyrimidines. Nat Prod Commun. https:\/\/doi.org\/10.1177\/1934578X231201037","journal-title":"Nat Prod Commun"},{"key":"11499_CR86","doi-asserted-by":"publisher","first-page":"82","DOI":"10.34172\/ajpr.1068","volume":"3","author":"G Chehardoli","year":"2023","unstructured":"Chehardoli G, Karimi F, Akbarzadeh T, Hariri R, Najafi Z (2023) Novel 2-amino-pyrano [3, 2-c] quinoline-3-carbonitrile derivatives bearing benzyloxy phenyl moiety as butyrylcholinesterase inhibitors: design, synthesis, in vitro evaluation, and molecular docking studies. Avicenna J Pharm Res 3:82\u201390","journal-title":"Avicenna J Pharm Res"},{"key":"11499_CR87","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.4155\/fmc-2022-0103","volume":"14","author":"S Hameed","year":"2022","unstructured":"Hameed S, Babatunde O, Salar U, Jabbar A, Chigurupati S, Solangi M et al (2022) Efficient one-pot synthesis of arylated pyrazole-fused pyran analogs: as leads to treating diabetes and Alzheimer\u2019s disease. Future Med Chem 14:1507\u20131526","journal-title":"Future Med Chem"},{"key":"11499_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104770","volume":"110","author":"S Shaikh","year":"2021","unstructured":"Shaikh S, Pavale G, Dhavan P, Singh P, Uparkar J, Vaidya SP et al (2021) Design, synthesis and evaluation of dihydropyranoindole derivatives as potential cholinesterase inhibitors against Alzheimer\u2019s disease. Bioorg Chem 110:104770","journal-title":"Bioorg Chem"},{"key":"11499_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202000924","volume":"18","author":"S Babaee","year":"2021","unstructured":"Babaee S, Chehardoli G, Akbarzadeh T, Zolfigol MA, Mahdavi M, Rastegari A et al (2021) Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents. Chem Biodivers 18:e2000924","journal-title":"Chem Biodivers"},{"key":"11499_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202100493","volume":"5","author":"B Zheng","year":"2021","unstructured":"Zheng B, Huo L (2021) Recent advances of furan and its derivatives based semiconductor materials for organic photovoltaics. Small Methods 5:e2100493","journal-title":"Small Methods"},{"key":"11499_CR91","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1021\/ol0063205","volume":"2","author":"F Stauffer","year":"2000","unstructured":"Stauffer F, Neier R (2000) Synthesis of tri- and tetrasubstituted furans catalyzed by trifluoroacetic acid. Org Lett 2:3535\u20133537","journal-title":"Org Lett"},{"key":"11499_CR92","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1021\/jm0604528","volume":"50","author":"B Plouvier","year":"2007","unstructured":"Plouvier B, Beatch GN, Jung GL, Zolotoy A, Sheng T, Clohs L et al (2007) Synthesis and biological studies of novel 2-aminoalkylethers as potential antiarrhythmic agents for the conversion of atrial fibrillation. J Med Chem 50:2818\u20132841","journal-title":"J Med Chem"},{"key":"11499_CR93","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1016\/0040-4039(95)00571-S","volume":"36","author":"E Corey","year":"1995","unstructured":"Corey E, Palani A (1995) A method for the selective oxidation of 1, 4-diols to lactols. Tetrahedron Lett 36:3485\u20133488","journal-title":"Tetrahedron Lett"},{"key":"11499_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/polym10060651","author":"Z Zhao","year":"2018","unstructured":"Zhao Z, Miao Y, Yang Z, Wang H, Sang R, Fu Y et al (2018) Effects of sulfuric acid on the curing behavior and bonding performance of tannin\u207bsucrose adhesive. Polymers. https:\/\/doi.org\/10.3390\/polym10060651","journal-title":"Polymers"},{"key":"11499_CR95","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/antibiotics3010039","volume":"3","author":"MJ Munoz-Davila","year":"2014","unstructured":"Munoz-Davila MJ (2014) Role of old antibiotics in the era of antibiotic resistance. Highlighted nitrofurantoin for the treatment of lower urinary tract infections. Antibiotics 3:39\u201348","journal-title":"Antibiotics"},{"key":"11499_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012849","volume":"19","author":"J Altcheh","year":"2025","unstructured":"Altcheh J, Grossmann U, Stass H, Springsklee M, Garcia-Bournissen F (2025) Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox. PLoS Negl Trop Dis 19:e0012849","journal-title":"PLoS Negl Trop Dis"},{"key":"11499_CR97","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5049\/EBP.2015.13.1.17","volume":"13","author":"SW Oh","year":"2015","unstructured":"Oh SW, Han SY (2015) Loop diuretics in clinical practice. Electrolyte Blood Press E BP 13:17\u201321","journal-title":"Electrolyte Blood Press E BP"},{"key":"11499_CR98","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/SGA.0000000000000359","volume":"42","author":"J Chen","year":"2019","unstructured":"Chen J, Brady P (2019) Gastroesophageal reflux disease: pathophysiology, diagnosis, and treatment. Gastroenterol Nurs 42:20\u201328","journal-title":"Gastroenterol Nurs"},{"key":"11499_CR99","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.14106","volume":"136","author":"S Inshutiyimana","year":"2025","unstructured":"Inshutiyimana S, Aleu MM, Abdinoor MA, Janoowalla MM, Norhayati N (2025) Diloxanide in amoebiasis management: unravelling the mechanism of action and effectiveness. Basic Clin Pharmacol Toxicol 136:e14106","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"11499_CR100","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1517\/14656566.2011.600688","volume":"12","author":"E Villa","year":"2011","unstructured":"Villa E, Magnoni MS, Micheli D, Canonica GW (2011) A review of the use of fluticasone furoate since its launch. Expert Opin Pharmacother 12:2107\u20132117","journal-title":"Expert Opin Pharmacother"},{"key":"11499_CR101","doi-asserted-by":"publisher","first-page":"21700","DOI":"10.1039\/D5RA01367D","volume":"15","author":"G Badshah","year":"2025","unstructured":"Badshah G, Alam A, Ayaz M, Elhenawy AA, Ahmad I, Ahmad S et al (2025) Synthesis, biological activities and computational studies of bis-Schiff base derivatives of 4-hydroxyacetophenone: insights from an in vitro, molecular docking and dynamics simulation approach. RSC Adv 15:21700\u201321714","journal-title":"RSC Adv"},{"key":"11499_CR102","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.21597\/jist.1117484","volume":"12","author":"M Koca","year":"2022","unstructured":"Koca M (2022) Synthesis and cholinesterase inhibitory potentials of (5-formylfuran-2-yl) methyl 3, 4-dimethoxy\/nitro benzoates. I\u011fd\u0131r \u00dcniversitesi Fen Bilimleri Enstit\u00fcs\u00fc Dergisi 12:1345\u20131357","journal-title":"I\u011fd\u0131r \u00dcniversitesi Fen Bilimleri Enstit\u00fcs\u00fc Dergisi"},{"key":"11499_CR103","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/cbdd.13825","volume":"97","author":"JA Miles","year":"2021","unstructured":"Miles JA, Ng JH, Sreenivas BY, Courageux C, Igert A, Dias J et al (2021) Discovery of drug-like acetylcholinesterase inhibitors by rapid virtual screening of a 6.9\u00a0million compound database. Chem Biol Drug Des 97:1048\u20131058","journal-title":"Chem Biol Drug Des"},{"key":"11499_CR104","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1080\/14756366.2019.1615484","volume":"34","author":"YH Hu","year":"2019","unstructured":"Hu YH, Yang J, Zhang Y, Liu KC, Liu T, Sun J et al (2019) Synthesis and biological evaluation of 3-(4-aminophenyl)-coumarin derivatives as potential anti-Alzheimer\u2019s disease agents. J Enzyme Inhib Med Chem 34:1083\u20131092","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11499_CR105","first-page":"333","volume":"15","author":"HE Temel","year":"2018","unstructured":"Temel HE, Altintop MD, \u00d6zdemir A (2018) Synthesis and evaluation of a new series of thiazolyl-pyrazoline derivatives as cholinesterase inhibitors. Turk J Pharm Sci 15:333\u2013338","journal-title":"Turk J Pharm Sci"},{"key":"11499_CR106","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.compbiolchem.2018.09.007","volume":"77","author":"MA Abbasi","year":"2018","unstructured":"Abbasi MA, Hassan M, Ur-Rehman A, Siddiqui SZ, Hussain G, Shah SAA et al (2018) 2-furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer\u2019s diseases: in vitro and in silico studies. Comput Biol Chem 77:72\u201386","journal-title":"Comput Biol Chem"},{"issue":"1","key":"11499_CR107","volume":"53","author":"G Hussain","year":"2017","unstructured":"Hussain G, Abbasi MA, Siddiqui SZ, Shah SA, Ashraf M, Ahmad I, Malik R, Lodhi MA, Khan FA, Shahid M, Fatima H (2017) Synthesis and in silico study of 2-furyl (4-{4-[(substituted) sulfonyl] benzyl}-1-piperazinyl) methanone derivatives as suitable therapeutic agents. Brazilian J Pharmaceut Sci. 53(1):e15237","journal-title":"Brazilian J Pharmaceut Sci."},{"key":"11499_CR108","doi-asserted-by":"publisher","first-page":"20728","DOI":"10.1021\/acsomega.4c02677","volume":"9","author":"A Mushtaq","year":"2024","unstructured":"Mushtaq A, Zahoor AF, Ahmad S, Saif MJ, Ul Haq A, Khan SG et al (2024) A comprehensive review on benzofuran synthesis featuring innovative and catalytic strategies. ACS Omega 9:20728\u201320752","journal-title":"ACS Omega"},{"key":"11499_CR109","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/bkcs.11384","volume":"39","author":"W Hwang","year":"2018","unstructured":"Hwang W, Kim H, Choi H, Kim J, Jeon WH, Lee PH et al (2018) Synthesis of aurones through silver\u2010catalyzed intramolecular cyclization from o\u2010alkynonylphenols. Bull Korean Chem Soc 39:397\u2013400","journal-title":"Bull Korean Chem Soc"},{"key":"11499_CR110","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/adsc.201300088","volume":"355","author":"CB Lavery","year":"2013","unstructured":"Lavery CB, Rotta-Loria NL, McDonald R, Stradiotto M (2013) Pd2dba3\/Bippyphos: a robust catalyst system for the hydroxylation of aryl halides with broad substrate scope. Adv Synth Catal 355:981\u2013987","journal-title":"Adv Synth Catal"},{"key":"11499_CR111","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1039\/c3ra46010j","volume":"4","author":"WJ Ang","year":"2014","unstructured":"Ang WJ, Tai C-H, Lo L-C, Lam Y (2014) Palladium-catalyzed annulation of internal alkynes in aqueous medium. RSC Adv 4:4921\u20134929","journal-title":"RSC Adv"},{"key":"11499_CR112","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40256-020-00401-5","volume":"20","author":"D Hamilton Sr.","year":"2020","unstructured":"Hamilton D Sr., Nandkeolyar S, Lan H, Desai P, Evans J, Hauschild C et al (2020) Amiodarone: A comprehensive guide for clinicians. Am J Cardiovasc Drugs 20:549\u2013558","journal-title":"Am J Cardiovasc Drugs"},{"key":"11499_CR113","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1592\/phco.30.9.904","volume":"30","author":"OO Oyetayo","year":"2010","unstructured":"Oyetayo OO, Rogers CE, Hofmann PO (2010) Dronedarone: a new antiarrhythmic agent. Pharmacotherapy 30:904\u2013915","journal-title":"Pharmacotherapy"},{"key":"11499_CR114","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s42995-023-00210-0","volume":"6","author":"G Zou","year":"2024","unstructured":"Zou G, Yang W, Chen T, Liu Z, Chen Y, Li T et al (2024) Griseofulvin enantiomers and bromine-containing griseofulvin derivatives with antifungal activity produced by the mangrove endophytic fungus Nigrospora sp. QQYB1. Marine Life Sci Technol. 6:102\u2013114","journal-title":"Marine Life Sci Technol."},{"key":"11499_CR115","first-page":"375","volume":"3","author":"S Kumar","year":"2016","unstructured":"Kumar S, Rao R (2016) Psoralen: a promising boon in topical manifestations. Int J Pharmacogn 3:375\u2013383","journal-title":"Int J Pharmacogn"},{"key":"11499_CR116","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/bjd.12466","volume":"169","author":"M Berneburg","year":"2013","unstructured":"Berneburg M, Herzinger T, Rampf J, Hoetzenecker W, Guenova E, Meisner C et al (2013) Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study. Br J Dermatol 169:704\u2013708","journal-title":"Br J Dermatol"},{"key":"11499_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26195790","author":"F Altwal","year":"2021","unstructured":"Altwal F, Padovan-Neto FE, Ritger A, Steiner H, West AR (2021) Role of 5-HT1A receptor in vilazodone-mediated suppression of L-DOPA-induced dyskinesia and increased responsiveness to cortical input in striatal medium spiny neurons in an animal model of Parkinson\u2019s disease. Molecules (Basel, Switzerland). https:\/\/doi.org\/10.3390\/molecules26195790","journal-title":"Molecules (Basel, Switzerland)"},{"key":"11499_CR118","doi-asserted-by":"publisher","first-page":"37234","DOI":"10.1039\/D4RA07741E","volume":"14","author":"MS Reddy","year":"2024","unstructured":"Reddy MS, Satyam K, Suresh S (2024) Design and application of intramolecular arylogous nitroaldol condensation to access 2-aryl-benzofuran and -indole derivatives and formal synthesis of saprisartan. RSC Adv 14:37234\u201337239","journal-title":"RSC Adv"},{"key":"11499_CR119","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1124\/molpharm.122.000638","volume":"103","author":"J Gao","year":"2023","unstructured":"Gao J, Yin H, Dong Y, Wang X, Liu Y, Wang K (2023) A novel role of uricosuric agent Benzbromarone in BK channel activation and reduction of airway smooth muscle contraction. Mol Pharmacol 103:241\u2013254","journal-title":"Mol Pharmacol"},{"key":"11499_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2025.1614462","volume":"13","author":"M El Fadili","year":"2025","unstructured":"El Fadili M, Ez-Zoubi A, Aloui M, Mujwar S, Abuelizz HA, Elhalaoui M et al (2025) Design of novel pyrazole and benzofuran-based derivatives as potent acetylcholinesterase inhibitors for Alzheimer\u2019s disease management. Front Chem 13:1614462","journal-title":"Front Chem"},{"key":"11499_CR121","doi-asserted-by":"crossref","unstructured":"Selim A, Ibrahim MA. Natural benzofuran derivatives as promising scaffold for alleviating Alzheimer symptoms: acetylcholinesterase inhibition, structure activity relationship and in silico studies. Natural product research. 2024:1\u20137.","DOI":"10.1080\/14786419.2024.2431998"},{"key":"11499_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29020315","author":"X Cui","year":"2024","unstructured":"Cui X, Huang Z, Deng S, Zhang Y, Li G, Wang L et al (2024) Benzofuran derivatives from Cortex Mori Radicis and their cholinesterase-inhibitory activity. Molecules. https:\/\/doi.org\/10.3390\/molecules29020315","journal-title":"Molecules"},{"key":"11499_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28166007","author":"S Saeed","year":"2023","unstructured":"Saeed S, Zahoor AF, Kamal S, Raza Z, Bhat MA (2023) Unfolding the antibacterial activity and acetylcholinesterase inhibition potential of benzofuran-triazole hybrids: synthesis, antibacterial, acetylcholinesterase inhibition, and molecular docking studies. Molecules. https:\/\/doi.org\/10.3390\/molecules28166007","journal-title":"Molecules"},{"key":"11499_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.882191","volume":"10","author":"Z Hasanvand","year":"2022","unstructured":"Hasanvand Z, Motahari R, Nadri H, Moghimi S, Foroumadi R, Ayati A et al (2022) Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease. Front Chem 10:882191","journal-title":"Front Chem"},{"key":"11499_CR125","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/00397911.2022.2056853","volume":"52","author":"AA Ahmed","year":"2022","unstructured":"Ahmed AA, Mekky AE, Sanad SM (2022) New piperazine-based bis (thieno [2, 3-b] pyridine) and bis (pyrazolo [3, 4-b] pyridine) hybrids linked to benzofuran units: synthesis and in vitro screening of potential acetylcholinesterase inhibitors. Synth Commun 52:912\u2013925","journal-title":"Synth Commun"},{"key":"11499_CR126","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1080\/14756366.2021.1940993","volume":"36","author":"Y Yun","year":"2021","unstructured":"Yun Y, Miao Y, Sun X, Sun J, Wang X (2021) Synthesis and biological evaluation of 2-arylbenzofuran derivatives as potential anti-Alzheimer\u2019s disease agents. J Enzyme Inhib Med Chem 36:1346\u20131356","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11499_CR127","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.bioorg.2018.11.043","volume":"84","author":"A Fais","year":"2019","unstructured":"Fais A, Kumar A, Medda R, Pintus F, Delogu F, Matos MJ et al (2019) Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivatives. Bioorg Chem 84:302\u2013308","journal-title":"Bioorg Chem"},{"key":"11499_CR128","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bioorg.2018.06.006","volume":"80","author":"F Abedinifar","year":"2018","unstructured":"Abedinifar F, Farnia SMF, Mahdavi M, Nadri H, Moradi A, Ghasemi JB et al (2018) Synthesis and cholinesterase inhibitory activity of new 2-benzofuran carboxamide-benzylpyridinum salts. Bioorg Chem 80:180\u2013188","journal-title":"Bioorg Chem"},{"key":"11499_CR129","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2174\/1570180813666160610124637","volume":"13","author":"B Pouramiri","year":"2016","unstructured":"Pouramiri B, Mahdavi M, Moghimi S, Firoozpour L, Nadri H, Moradi A et al (2016) Synthesis and antiacetylcholinesterase activity evaluation of new 2-aryl benzofuran derivatives. Lett Drug Des Discov 13:897\u2013902","journal-title":"Lett Drug Des Discov"},{"key":"11499_CR130","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejmech.2015.08.061","volume":"103","author":"M Mostofi","year":"2015","unstructured":"Mostofi M, Mohammadi Ziarani G, Mahdavi M, Moradi A, Nadri H, Emami S et al (2015) Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors. Eur J Med Chem 103:361\u2013369","journal-title":"Eur J Med Chem"},{"key":"11499_CR131","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejmech.2015.07.005","volume":"102","author":"BZ Kurt","year":"2015","unstructured":"Kurt BZ, Gazioglu I, Basile L, Sonmez F, Ginex T, Kucukislamoglu M et al (2015) Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer\u2019s disease. Eur J Med Chem 102:80\u201392","journal-title":"Eur J Med Chem"},{"key":"11499_CR132","doi-asserted-by":"publisher","first-page":"21706","DOI":"10.1021\/acsomega.4c00771","volume":"9","author":"A Gaspar","year":"2024","unstructured":"Gaspar A, Garrido E, Borges F, Garrido J (2024) Biological and medicinal properties of natural chromones and chromanones. ACS Omega 9:21706\u201321726","journal-title":"ACS Omega"},{"key":"11499_CR133","volume-title":"Corey-Bakshi-Shibata (CBS) reduction","author":"JJ Li","year":"2006","unstructured":"Li JJ (2006) Corey-Bakshi-Shibata (CBS) reduction, 3rd edn. Springer, Berlin, Heidelberg","edition":"3"},{"key":"11499_CR134","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bmcl.2007.11.081","volume":"18","author":"SB Abdel Ghani","year":"2008","unstructured":"Abdel Ghani SB, Weaver L, Zidan ZH, Ali HM, Keevil CW, Brown RC (2008) Microwave-assisted synthesis and antimicrobial activities of flavonoid derivatives. Bioorg Med Chem Lett 18:518\u2013522","journal-title":"Bioorg Med Chem Lett"},{"key":"11499_CR135","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1016\/S0040-4020(01)97034-6","volume":"30","author":"A Nohara","year":"1974","unstructured":"Nohara A, Umetani T, Sanno Y (1974) Studies on antianaphylactic agents\u2014I: a facile synthesis of 4-oxo-4H-1-benzopyran-3-carboxaldehydes by Vilsmeier reagents. Tetrahedron 30:3553\u20133561","journal-title":"Tetrahedron"},{"key":"11499_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106172","volume":"178","author":"PG Puzzovio","year":"2022","unstructured":"Puzzovio PG, Br\u00fcggemann TR, Pahima H, Mankuta D, Levy BD, Levi-Schaffer F (2022) Cromolyn sodium differentially regulates human mast cell and mouse leukocyte responses to control allergic inflammation. Pharmacol Res 178:106172","journal-title":"Pharmacol Res"},{"key":"11499_CR137","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.intimp.2016.01.003","volume":"32","author":"A Sinniah","year":"2016","unstructured":"Sinniah A, Yazid S, Perretti M, Solito E, Flower RJ (2016) The role of the Annexin-A1\/FPR2 system in the regulation of mast cell degranulation provoked by compound 48\/80 and in the inhibitory action of nedocromil. Int Immunopharmacol 32:87\u201395","journal-title":"Int Immunopharmacol"},{"key":"11499_CR138","volume":"9","author":"K Kumar","year":"2022","unstructured":"Kumar K, Das DK, Singh A (2022) A prospective study of the pattern of antispasmodic drug use in urological disorders with detrusor overactivity. Eur J Mol Clin Med 9:9891","journal-title":"Eur J Mol Clin Med"},{"key":"11499_CR139","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/164_2016_72","volume":"237","author":"T Tamada","year":"2017","unstructured":"Tamada T, Ichinose M (2017) Leukotriene receptor antagonists and antiallergy drugs. Handb Exp Pharmacol 237:153\u2013169","journal-title":"Handb Exp Pharmacol"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11499-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:01:55Z","timestamp":1791180115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11499-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":139,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11499"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11499-1","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare none of AI used in this manuscript.","order":4,"name":"Ethics","label":"AI","group":{"name":"EthicsHeading","label":"Declarations"}}]}}